Vivasure Raises Funds to Advance Development and Approval of PerQseal Vessel Closure Device Portfolio

May 17, 2022—Vivasure Medical, an Ireland-based company focused on fully absorbable technology for percutaneous vessel closure, announced the cl

Related Keywords

New York ,United States ,Ireland ,Azeem Latib ,Health Economics Fund ,Life Sciences ,Structural Heart Interventions At Montefiore Health System ,Vivasure Medical ,Fountain Healthcare Partners ,Orchestra Biomed ,Economics Fund ,Evonik Venture ,Perqseal Blue ,Chief Executive Officer ,Section Head ,Interventional Cardiology ,Structural Heart Interventions ,Montefiore Health System ,Vessel Closure ,Vivasure ,Absorbable ,Financing ,Large Bore ,Percutaneous ,Transcatheter ,Endovascular ,Ardiovascular ,Erqseal ,Essel Puncture ,Rterial Closure ,Enous Closures ,Venous Procedure ,Ravenous ,